Stimcell Energetics (STME) Return on Capital Employed (2017 - 2019)
Stimcell Energetics' quarterly Return on Capital Employed came in at 6.18% in Q1 2019, down 125.35% quarter-over-quarter from 24.39% in Q4 2018.
Stimcell Energetics has reported Return on Capital Employed for 3 years, with the latest figure at 6.18% in Q1 2019.
- For the quarter ending Q1 2019, Return on Capital Employed changed N/A year-over-year to 6.18%; the trailing twelve-month figure through Feb 2019 stood at 6.18% (changed N/A YoY), and the FY2017 full-year result was 103.27%, changed N/A from the prior year.
- Return on Capital Employed for Q1 2019 stood at 6.18%, down from 24.39% in the prior quarter.
- The five-year high for Return on Capital Employed was 106.24% in Q2 2017, with the low at 6.18% in Q1 2019.
- Average Return on Capital Employed over 3 years is 44.8%, with a median of 39.56% recorded in 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2019 | -6.18% |
| Nov 30, 2018 | 24.39% |
| Aug 31, 2018 | 54.74% |
| May 31, 2017 | 106.24% |